Status:

COMPLETED

Effect of Intermittent Hypoxia on Ischemia-reperfusion Injury in Healthy Individuals

Lead Sponsor:

University of Texas at Austin

Conditions:

Intermittent Hypoxia

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The objective of the present study is to determine whether intermittent hypoxia protects against ischemia-reperfusion injury in young and older healthy individuals. The investigators hypothesize that ...

Detailed Description

Ischemic heart disease represents the most common form of cardiovascular disease and the main cause of mortality in the United States. Ischemic heart disease originates from an inadequate blood supply...

Eligibility Criteria

Inclusion

  • Men and women aged 18 to 80 years old

Exclusion

  • Have high blood pressure (above 130/80 mmHg)
  • Are smokers
  • Are pregnant
  • Have a history of cardiovascular disease, diabetes or lung disease
  • Are taking medication affecting the cardiovascular system
  • Carpal tunnel syndrome

Key Trial Info

Start Date :

May 30 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2022

Estimated Enrollment :

41 Patients enrolled

Trial Details

Trial ID

NCT05423470

Start Date

May 30 2019

End Date

July 1 2022

Last Update

December 7 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Unviersity of Texas at Austin

Austin, Texas, United States, 78712